BM&FBOVESPA today began trading 19 new Unsponsored Level I BDR programs (BDR NP), issued by Deutsche Bank SA PN. BDRs are securities issued in Brazil by depository institutions and which have shares of foreign companies as underlying. They are traded on the cash market from 10:00 a.m.to 5:00 p.m., with round lots of 100 BDRs. The new programs authorized for trading from today are for BDRs with shares of the following companies as underlying:
|
Company |
BDR Ticker |
|
ABBVie Inc. |
ABBV34 |
|
Biogen Inc. |
BIIB34 |
|
BlackRock, Inc. |
BLAK34 |
|
Cognizant Technology Solutions |
CTSH34 |
|
Costco Wholesale Corporation |
COWC34 |
|
CVS Health Corporation |
CVSH34 |
|
Delta Air Lines, Inc. |
DEAI34 |
|
E.I. du Pont de Nemours and Company |
DUPO34 |
|
EMC Corporation |
EMCC34 |
|
Express Scripts Holding Company |
ESRX34 |
|
Gilead Sciences, Inc. |
GILD34 |
|
Macy's, Inc. |
MACY34 |
|
Medtronic Public Limited Company |
MDTC34 |
|
Ross Stores, Inc. |
ROST34 |
|
Salesforce.com, Inc. |
SSFO34 |
|
The Charles Schwab Corporation |
SCHW34 |
|
The Gap, Inc. |
GPSI34 |
|
The Travelers Companies, Inc. |
TRVC34 |
|
Thermo Fisher Scientific Inc. |
TMOS34 |
The BDR NP program
The Unsponsored Level I BDR program (BDR NP) is an important BM&FBOVESPA initiative that aims to expand the portfolio of listed products. With this launch, the BDR NP portfolio now contains 104 programs. For the investor, the product is an alternative for expanding the range of exposure in the international market, with the possibility of developing strategies, investment diversification and arbitrage between local and foreign assets. For more information about the product please visit the BM&FBOVESPA website.
